sadly, we're in the dark; my gut tells me that there is a serious drive for this to go through, which can be as a result of avoiding higher risk scenarios - a hostile takeover, going it alone, parting the pipeline out...
I can't recall if we ever figured out why they acquired a gel/fill machine awhile back but since we can only speculate, any thoughts on circumventing FDA and pursuing libi to market sans approval, then circling back on efficacy studies or using efficacy results from others and go through the approval process again while we're actively churning out libi to the market...maintain cash flow while we're proving efficacy?
also, nutsy got banned yesterday, don't know what he said, but there you go, in case anyone was wondering where he is.
-RG
